Effects of palonosetron for prophylaxis of postoperative nausea and vomiting in high-risk patients undergoing total knee arthroplasty: A prospective, randomized, double-blind, placebo-controlled study.
Jung-Hee RyuYoung-Tae JeonByunghun MinJin-Young HwangHye-Min SohnPublished in: PloS one (2018)
Palonosetron prophylaxis reduced the incidence and severity of PONV in high-risk patients managed with multimodal pain protocol for 48 h, notably 2-24 h after TKA.
Keyphrases
- total knee arthroplasty
- patients undergoing
- double blind
- end stage renal disease
- pain management
- chronic kidney disease
- ejection fraction
- newly diagnosed
- clinical trial
- chronic pain
- total hip
- randomized controlled trial
- peritoneal dialysis
- risk factors
- neuropathic pain
- placebo controlled
- chemotherapy induced
- spinal cord injury
- study protocol